Life Sciences Panel Discussion

Slides:



Advertisements
Similar presentations
Best practice partnership models
Advertisements

National Intellectual Property Strategies, Some Examples and Their Significance June, 2005 Maputo, Mozambique WIPO Intellectual Property and New Technologies.
Facilities Management 2013 Manager Enrichment Program U.Va.’s Strategic Planning Initiatives Colette Sheehy Vice President for Management and Budget December.
Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni, Secretary General Interpharma.
Stepping up the Pace Together Dynamic Partnerships Across Community, Academic and Policy Sectors Kevin Miles - Manager of Health Programmes.
Index 2008Index 2010 # Companies Originators 1820 # Companies Generic Manufacturers 2 Same Index, adjusted weights 7 Separate Index, adjus weights / KPIs.
WIPO’s Strategies on Intellectual Property and Economic Development WIPO’s Strategies on Intellectual Property and Economic Development United Nations.
INTELLECTUAL PROPERTY AND ACCESS TO INFORMATION IN ZIMBABWE Kathy Matsika(Ms) National University of Science and Technology.
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
Basic Definitions and Drivers (Sustainability Reporting) Introduction and scene setting.
A PPP managed by FNIH Partners are NIH, FDA, CMS, and private industry Barbara B. Mittleman, M.D. Director, NIH PPP Program Bioinformatics Forum March.
Celebrating Sustainability Leaders: The Reinhard Mohn Prize 2013 UNOSD-Workshop Incheon, November 16, 2012.
All logos, trademarks, trade names and graphics used herein are the property of their respective owners© Infotech Enterprises Ltd All rights reserved.
Bridging Gap in Global Innovation – From need to Access, Said Business School, University of Oxford 9-13 September 2007 Strategies for Managing Innovation.
Public, Private & Faith-based Partnerships in Papua New Guinea How to provide innovative, needs-based programs to support HIV health care capacity building.
Developing the New Zealand Energy Strategy IPS Roundtable Series on energy sustainability 4 August 2006 Stuart Calman.
Strategic Plan We operate in a challenging environment Challenging macro- economic environment Consumer confidence Transfer of cost towards.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Presentation on Covenant University Strategic Plan Conrad A. Omonhinmin Ph.D Department of Biological Sciences, Covenant University, Ota.
Sustainable Approaches to Opening Access to Medical Inventions James Love Wizards of OS Berlin 15 Sept 06.
© IFPMA 2009WIPO Open-ended Forum on Proposed Development Agenda Projects - 13/10/2009 IFPMA views on the strategic use of information for sustainable.
Science and Technology Development Fund: Supporting Research and Technology Development Eng. Mohamed Nagaty Innovation Manager November 22 nd, 2010.
Delivering Reform: An Industry Perspective Colette Goldrick, Director ABPI Northern Ireland 22 April 2015.
Adaptive Licensing UK. Content What is adaptive licensing? Draft criteria for pilot candidate selection EMA Road Map 2015 and work programme 2012 UK perspective.
THE IMPORTANCE OF IPR ACROSS THE LIFECYCLE OF INNOVATION Bob Stembridge Principal Patent Analyst, IP & Science.
National IPR Policy : Takeaways for Pharma & Tech Industry
Consultancy and Training Trends and Service Offer
Ron marchant CB FRSA Access to Knowledge and Technologies, IP and Strategies for Green Technologies WIPO ASIA-PACIFIC CONFERENCE ON NATIONAL IP STRATEGIES.
Responsible Research and Innovation as a part of Regional Innovation Eco-system Rhys Thomas Head of Innovation System and Engagement Pennaeth System Arloesi.
Topic 3A SEMANTIC INTEROPERABILITY: REUSE OF EHR DATA Mats Sundgren.
CONTRIBUTING TO THE ELABORATION AND IMPLEMENTATION OF STRATEGIES FOR INTELLECTUAL PROPERTY (IP) DEVELOPMENT Loretta Asiedu Senior Counselor WIPOWindhoek,
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
Overview and Strategic Direction Presenter: April Golden February 24, 2016.
Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 6 th September 2011 Enrico Chesta.
WWF and The Coca-Cola Company Partnership Overview April 2014.
Systemic change by streamlined innovation: personalised medicine Novembre 8, 2013.
Gwendolyn Ryals, Look at Me Artwork from The Creative Center Janey Shin, Director, Real World Evidence Government Affairs and Market Access CADTH Symposium.
BioMedical Cluster New opportunities for innovators and investors with Bio-Medical Cluster of Skolkovo Foundation Innovation in Medical Technologies Conference,
Best Practices for a Full Value Chain Approach Open Innovation Matthew C. Heim, Ph.D. President, NineSigma Inc.
TRADE NEGOTIATION ON PHARMACETICALS PRESENTED BY CHOGO,MALESO (092SIS10).
Industrial development and access to medicines: Identifying and creating mutual interests Maureen Mackintosh, The Open University UK Based on work led.
Value Creation and Capture with Open Source Software: Understanding the Role of Value Networks Lorraine Morgan National University of Ireland, Galway.
Achieving 2030 Agenda for Sustainable Development
Placebo / Standard of Care (PSoC)
2016 TO 2019 STRATEGIC PLAN OUTLINE
Health Technology Assessment
— Creative india, innovative indiA
Intellectual Property Protection and Access to Medicines
Director Department for Transition and Developed Countries
From ambition to reality
IPR’s: new challenges and opportunities
INTRODUCTION TO ISO 9001:2015 FOR IMPLEMENTATION Varinder Kumar CISA, ISO27001 LA, ISO 9001 LA, ITIL, CEH, MEPGP IT, Certificate course in PII & Privacy.
University & Industry Collaborative IP Development
Introduction to TransCelerate
A science-led global healthcare company with a special purpose
Peter Chibatamoto HIV/AIDS Policy Advisor
Global Cement and Concrete Association
Kaisa Immonen EPF Director of Policy
Sustainability Symposium
o UTLINE… Publicly financed research: policy issues around IPR
Formulation and Development of National IP Strategy
Implementing the 2030 Agenda in the Asia- Pacific region, January 2019, Shanghai Institutional arrangements to facilitate coherence in sustainable.
Compliance and the Digitalization Example of Healthcare Sector
The Canadian University Business Model
Being a Local University: Towards New Assessment Tools and Indicators Dr John H Smith Senior Adviser, European University Association (EUA) Brussels Member,
Company and Product overview
An Agency Perspective on Plain Language Summaries of Publications
Prof. Kiran Kalia, Director NIPER Ahmedabad
Enhancing WMO and CEOS COLLABORATION
Humboldt Space Research Mission America. Humboldt Space Co. adopts a forward thinking stance in scientific research and technical development. Our policy.
Presentation transcript:

Life Sciences Panel Discussion April 5-6, 2018 Fordham University Stephane Drouin

UCB’s proposition Creating value for patients Focus on innovation ADAPTABLE IP STRATEGIES Focus on innovation Engage in political and public debates Evolve with new technologies VALUE-BASED INNOVATION Focus expertise Engage partners and healthcare stakeholders Open collaboration and Risk-sharing

Shifting the IP paradigm UCB’s IP proposition Pharmaceutical companies abuse IP to prolong exclusivity Broad and non-transparent IP portfolios A selective and measurable IP policy focused on core innovation to strengthen the acceptance of IP and our industry A patent portfolio aligned with UCB’s PVS, protecting only UCB solutions that are valuable to patients and society Public Perception UCB

Innovation that makes a tangible difference to patients Streamlining our patent portfolio has helped UCB to focus on CORE INNOVATION: Innovation that makes a tangible difference to patients

UCB’s ‘core innovation’ proposition What it means and how it differs - 25 % Pushing our company to find the right drug for the right patient Patient-centric medicine providing access and sustainable healthcare meeting patient needs Make the link between value we create and what we protect

…DELIVERING PATIENT SOLUTIONS IS. Patents are not the goal… …DELIVERING PATIENT SOLUTIONS IS.

Thanks!

Pat-INFORMED Database Patent Information Initiative for Medicines (Pat-INFORMED) Joint IFPMA and WIPO initiative announced at WIPO General Assembly (10/2017). Aims to enhance the reputation of intellectual property as a foundation of global healthcare. Welcomed by WHO, the Gates Foundation, the Medicines Patent Pool and many member states. UCB and more than 20 other companies committed to make global patent information, similar to the US “Orange book”, on medicines available via Pat- INFORMED. Initial database covers granted patents for small molecule products within oncology, hepatitis C, cardiovascular, HIV, diabetes, respiratory therapy areas, and any products on the WHO Essential Medicines List.